AbbVie Inc.
ABBV 215.70 (0.00%) 0.00
Health Care
Biotechnology
Quality Checklist 1/8
Est. EPS Growth > 5%
5Y Shares Out Change < 0%
ROIC > 10%
Debt/Equity < 1
Current Ratio > 1
Quick Ratio > 1
Net Margin > 10%
Past Net Income CAGR > 0%
0.0%of Portfolio
My holdings
Day change:
Total change:
Shares:Cost basis:
Market cap: $381.10(B)
EV: $444.66(B)
Total Equity: $-6.61(B)
Earnings date: Apr-24-2026
P/E: 106.26
Forward P/E: 15.14
P/FCF: 19.07
P/S: 6.08
P/B: N/A
EPS: $2.0
EPS (fwd): $14.3
FCF/share: $11.3
Revenue/share: $35.5
Book value/share: $-3.8
ROIC: 3.3%
ROA: 1.7%
ROE: 140.9%
Debt/Equity: 48
Current Ratio: 0.80
Gross margin: 72.0%
Operating margin: 24.1%
Net margin: 5.8%
Dividend/share: $6.7
Div. yield: 3.12%
TTM Financials
Income (TTM)
Revenue$62.82(B)
Gross profit$45.25(B)
EBITDA$29.91(B)
Net income$3.63(B)
Gross margin72.0%
Operating margin24.1%
Net margin5.8%
Shares outstanding1.77(B)
Balance sheet
Total assets$136.46(B)
Current assets$33.53(B)
Total liabilities$143.07(B)
Current liabilities$42.10(B)
Cash & Short-term inv.$9.39(B)
Long-term debt$64.57(B)
Total intangibles$86.44(B)
PP&E$5.69(B)
Cash flow (TTM)
FCF$19.98(B)
CapEx$-1.24(B)
Dividends paid$-11.82(B)
Stock issued$172.00(M)
Stock repurchased$-1.51(B)
Stock-based comp.$1.08(B)
Debt issued$11.70(B)
Debt repaid$-9.07(B)